HAMMOND, La., Sept. 19, 2025 (GLOBE NEWSWIRE) — The North Oaks Health System family joined with community leaders and dignitaries today to celebrate a major milestone with a ribbon cutting for North Oaks Clinic Building 3. The five-story, 96,000-square-foot clinic represents a $50 million investment by North Oaks in expanding access to coordinated specialty healthcare […]
North Oaks Unveils $50 Million, 5-Story Specialty Clinic Expansion in Hammond New 5-Story Clinic Building Expands Specialty Care, Strengthens Regional Healthcare Infrastructure GlobeNewswire September 19, 2025 HAMMOND, La., Sept. 19, 2025 (GLOBE NEWSWIRE) — The North Oaks Health System family joined with community leaders and dignitaries today to celebrate a major milestone with a ribbon
First of its kind ERISA class action addressed unprecedented use of risky proprietary investment funds for managing a 401(k) plan. Strategy allegedly wiped out 401(k) and aided in GWA LLC bankruptcy. HARTFORD, CT / ACCESS Newswire / September 19, 2025 / Today, a federal judge granted final approval of a $7.9 million settlement to resolve
(NASDAQ:MBX), CARMEL, Ind., Sept. 19, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that it will provide topline results from its Phase 2 clinical trial of potential once-weekly canvuparatide
MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22 GlobeNewswire September 19, 2025 CARMEL, Ind., Sept. 19, 2025 (GLOBE NEWSWIRE) — MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for
The National Institute of Building Sciences (NIBS) announced it has formally assumed management and development of the Sustainable Facilities Tool (SFTool), a widely respected digital platform originally developed by the U.S. General Services Administration (GSA). Moving forward, the platform will be known as the High Performance Building Guide (HPBG), a new name that reflects its
Singapore, Sept. 19, 2025 (GLOBE NEWSWIRE) — – Mureka, the AI-powered music creation platform, today announced the launch of Music Agent Studio, a new feature inspired by insights into how people want to express themselves musically in daily life. Music Agent Studio reflects Mureka's vision of AI not just as a songwriting tool, but as
(CNSX:MDMA.CN),(CNSX:MDMA),(OTC US:MDXXF),(Other OTC:MDXXF), TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company“) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo(TM) MDMA), is pleased to announce that it has filed an amended and restated preliminary short form
Mureka AI Launches Music Agent Studio, Reimagining How People Create Music in Everyday Situations GlobeNewswire September 19, 2025 Singapore, Sept. 19, 2025 (GLOBE NEWSWIRE) — – Mureka, the AI-powered music creation platform, today announced the launch of Music Agent Studio, a new feature inspired by insights into how people want to express themselves musically in
PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus GlobeNewswire September 19, 2025 TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company“) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo(TM) MDMA), is pleased to announce that